Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Thyroid dysfunction in Chinese hepatitis C patients: Prevalence and correlation with TPOAb and CXCL10.

Zhang RW, Shao CP, Huo N, Li MR, Xi HL, Yu M, Xu XY.

World J Gastroenterol. 2015 Sep 7;21(33):9765-73. doi: 10.3748/wjg.v21.i33.9765.

2.

Autoantibodies in chronic hepatitis C: A clinical perspective.

Narciso-Schiavon JL, Schiavon Lde L.

World J Hepatol. 2015 May 18;7(8):1074-85. doi: 10.4254/wjh.v7.i8.1074. Review.

3.

Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

McLachlan SM, Rapoport B.

Endocr Rev. 2014 Feb;35(1):59-105. doi: 10.1210/er.2013-1055. Epub 2013 Dec 4. Review.

4.

Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.

Nair Kesavachandran C, Haamann F, Nienhaus A.

PLoS One. 2013;8(2):e55364. doi: 10.1371/journal.pone.0055364. Epub 2013 Feb 1. Review.

5.

Thyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.

Yan Z, Fan K, Fan Y, Wang X, Mao Q, Deng G, Wang Y.

Hepat Mon. 2012 Sep;12(9):e6390. doi: 10.5812/hepatmon.6390. Epub 2012 Sep 30.

6.

Hepatitis C and interferon induced thyroiditis.

Tomer Y.

J Autoimmun. 2010 May;34(3):J322-6. doi: 10.1016/j.jaut.2009.11.008. Review.

7.

Interferon induced thyroiditis.

Tomer Y, Menconi F.

Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):703-12. doi: 10.1016/j.beem.2009.07.004. Review.

8.

Interferon alpha treatment and thyroid dysfunction.

Tomer Y, Blackard JT, Akeno N.

Endocrinol Metab Clin North Am. 2007 Dec;36(4):1051-66; x-xi. Review.

10.

Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.

Wesche B, Jaeckel E, Trautwein C, Wedemeyer H, Falorni A, Frank H, von zur Mühlen A, Manns MP, Brabant G.

Gut. 2001 Mar;48(3):378-83.

Supplemental Content

Support Center